Powered by OpenAIRE graph

Treatment de-escalation of IO-TKI combination in 1st-line advanced or metastatic renal cell carcinoma (RCC) not having progressed at 12 weeks (the HOLIDAY trial) - Randomized phase II near-equivalence/non-inferiority de-escalation trial

assignment_turned_inproject01 Jul 2023(Started)-31 Oct 2023(Ended)Closed
Funder: Swiss National Science FoundationProject code: 221719
Funded under: Programmes | Investigator Initiated Clinical Trials (IICT) Funder Contribution: 4,860

Treatment de-escalation of IO-TKI combination in 1st-line advanced or metastatic renal cell carcinoma (RCC) not having progressed at 12 weeks (the HOLIDAY trial) - Randomized phase II near-equivalence/non-inferiority de-escalation trial

Partners
IOSI , EOC
Data Management Plans
argos Start a new DMP in Argos
Powered by OpenAIRE graph

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
arrow_drop_down
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=snsf________::0057b8630a4b1b82a06f5ec8fb19e7e1&type=result"></script>');
-->
</script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

No option selected
arrow_drop_down